A phase IIb study of selinexor in combination with daratumumab in patients with daratumumab-refractory multiple myeloma

• DOI: 10.3324/haematol.2024.287053
• Publication Date: 2025-04-03T07:56:07Z
• Authors: Noa Biran; Eli Zolotov; David Vesole; Harsh Parmar; Pooja Phull; Kimberley Doucette; Patrick Roney; Jaeil Ahn; Rena Feinman; Joshua Zenreich; Palka Anand; Monique Pace; Alexandra Della Pia; Bianca DeAgresta; Lisa Biamonte; Adolfo Aleman; Ella Rutanen; Aimee Chappell; Susan Kumka; David S. Siegel

Not available.